Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EXELIXIS, INC. Director's Dealing 2024

Aug 10, 2024

30561_dirs_2024-08-09_b2751f90-19b2-4511-aa2e-6d25b56c45e2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXELIXIS, INC. (EXEL)
CIK: 0000939767
Period of Report: 2024-08-09

Reporting Person: Senner Christopher J. (EVP and CFO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-08-09 Common Stock M 125000 $24.41 Acquired 846680 Direct
2024-08-09 Common Stock S 125000 $27.19 Disposed 721680 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-08-09 Option (right to buy) $24.41 M 125000 Disposed 2024-10-02 Common Stock (125000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 2723 Indirect

Footnotes

F1: Includes 272,874 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.

F2: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $27.08 to $27.35. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.

F3: Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of August 8, 2024.

F4: The option, representing the right to purchase a total of 125,000 shares of Exelixis, Inc. common stock became fully exercisable on October 3, 2021.